Second phase III trial of MED2002 for the Treatment of Erectile Dysfunction (ED)
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Nitroglycerin (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Sponsors Futura Medical
- 01 Dec 2017 New trial record
- 29 Nov 2017 According to a Futura Medical media release, data from the PK study (profile 283168) will determine the dosages to be used in this and other trial (see profile 283164).
- 29 Nov 2017 According to a Futura Medical media release, the Medicines and Healthcare products Regulatory Agency and the Medicines Evaluation Board has approved two Phase III trials (this and profile 283164) and one pharmacokinetic trial (see profile 283168).